Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil

By UNGER THOMAS  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 14-18

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Treatment with Candesartan Cilexetil does not Affect Glucose Homeostasis or Serum Lipid Profile in Patients with Mild Hypertension and Type II Diabetes

By TRENKWALDER PETER   DAHL KETIL   LEHTOVIRTA MIKKO   MULDER HENK  

Blood Pressure, Vol. 7, Iss. 3, 1998-08 ,pp. : 170-175

Informa Healthcare

Access to resources Recommend Favorite

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation

By Isobe Aki   Takeda Takashi   Sakata Masahiro   Miyake Asako   Yamamoto Toshiya   Minekawa Ryoko   Nishimoto Fumihito   Oskamoto Yoko   Walker Cheryl Lyn   Kimura Tadashi  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 440-446

Oxford University Press

Access to resources Recommend Favorite